214 related articles for article (PubMed ID: 24022467)
1. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
Nagao M; Sato Y; Yamauchi A
PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
4. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
[TBL] [Abstract][Full Text] [Related]
7. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
8. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
Daraei A; Salehi R; Mohamadhashem F
Mol Biol Rep; 2012 May; 39(5):5219-24. PubMed ID: 22173719
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
11. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
Lee YS; Kim H; Wu TX; Wang XM; Dionne RA
Clin Pharmacol Ther; 2006 May; 79(5):407-18. PubMed ID: 16678543
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.
Hubner RA; Muir KR; Liu JF; Logan RFA; Grainge MJ; Houlston RS;
Int J Cancer; 2007 Nov; 121(9):2001-2004. PubMed ID: 17640058
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
Brasky TM; Bonner MR; Moysich KB; Ochs-Balcom HM; Marian C; Ambrosone CB; Nie J; Tao MH; Edge SB; Trevisan M; Shields PG; Freudenheim JL
Breast Cancer Res Treat; 2011 Feb; 126(1):157-65. PubMed ID: 20676755
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase genes and colon and rectal cancer.
Slattery ML; Lundgreen A; Wolff RK
Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
[TBL] [Abstract][Full Text] [Related]
16. TERT's role in colorectal carcinogenesis.
Pellatt AJ; Wolff RK; Herrick J; Lundgreen A; Slattery ML
Mol Carcinog; 2013 Jul; 52(7):507-13. PubMed ID: 22351525
[TBL] [Abstract][Full Text] [Related]
17. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
Thompson CL; Plummer SJ; Merkulova A; Cheng I; Tucker TC; Casey G; Li L
World J Gastroenterol; 2009 May; 15(18):2240-4. PubMed ID: 19437564
[TBL] [Abstract][Full Text] [Related]
18. Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population.
Shalaby MA; Nounou HA; Ms A; O A; Azzam N; Saeed HM
Asian Pac J Cancer Prev; 2014; 15(12):4989-94. PubMed ID: 24998576
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
20. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer.
Dzhugashvili M; Luengo-Gil G; García T; González-Conejero R; Conesa-Zamora P; Escolar PP; Calvo F; Vicente V; Ayala de la Peña F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):595-602. PubMed ID: 25304949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
